<p>eGFR, estimated glomerular filtration rate (mL/min/1.73 m<sup>2</sup>); PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; CAD, coronary artery disease; AMI, acute myocardial infarction; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; STEMI, ST elevation myocardial infarction; aSBP, systolic blood pressure; HR, heart rate. Continuous variables are presented as median values (with interquartile ranges) and were analyzed by the Kruskal-Wallis test followed by Dunn's post-test. Categorical variables are presented as percentages and were analyzed by χ<sup>2</sup> statistics with Bonferroni correction for post-test multiple comparisons.</p>*<p>p<0.001,</p>†<p>p = 0.009,</p>**<p>...
<p>P-value < 0.05 = *, p value < 0.01 = **, all values are compared with eGFR ≥90 ml/min/1.73 m² gro...
<p>*p-interaction (Wald test) between eGFR category and inpatient revascularisation and mortality: 0...
Objectives: To validate the performance of the most commonly used formulas for estimation of glomeru...
<p>a-eGFR, admission estimated glomerular filtration rate (mL/min/1.73 m<sup>2</sup>); PCI, percutan...
<p>Comparison between two groups of patients by the student’s <i>t</i> test, Pearson <i>x</i><sup>2<...
<p>PCI, percutaneous coronary intervention; coronary artery bypass graft; ACE, angiotensin convertin...
<p>Abbreviations. ABI, ankle-brachial index; CKD, chronic kidney disease; eGFR, estimated glomerular...
<p>NYHA, New York Heart Association; ACS, acute coronary syndrome; CAD, coronary artery disease; CHF...
*<p>1: Stage 1 chronic kidney disease (CKD), estimated glomerular filtration rate (eGFR) ≥90 ml/min/...
<p>Abbreviations. BP, blood pressure; eGFR, estimated glomerular filtration rate; ACEI, angiotensin ...
<p>Data are expressed as number (percentage) for categorical variables and mean±SD or median (25<sup...
<p>Data are presented as mean ± SEM or median (inter-quartile range [IQR]) for continuous variables ...
<p>*p-interaction (Wald test) between eGFR category and inpatient revascularisation and mortality: 0...
<p>Groups 1, 2, 3 and 4 were made up of patients with eGFR ≥45 ml/min/1.73 m<sup>2</sup> without PAD...
<p>Patients have been assigned to two groups by the median of eGFR at baseline (99.19 ml/min/1.73 m<...
<p>P-value < 0.05 = *, p value < 0.01 = **, all values are compared with eGFR ≥90 ml/min/1.73 m² gro...
<p>*p-interaction (Wald test) between eGFR category and inpatient revascularisation and mortality: 0...
Objectives: To validate the performance of the most commonly used formulas for estimation of glomeru...
<p>a-eGFR, admission estimated glomerular filtration rate (mL/min/1.73 m<sup>2</sup>); PCI, percutan...
<p>Comparison between two groups of patients by the student’s <i>t</i> test, Pearson <i>x</i><sup>2<...
<p>PCI, percutaneous coronary intervention; coronary artery bypass graft; ACE, angiotensin convertin...
<p>Abbreviations. ABI, ankle-brachial index; CKD, chronic kidney disease; eGFR, estimated glomerular...
<p>NYHA, New York Heart Association; ACS, acute coronary syndrome; CAD, coronary artery disease; CHF...
*<p>1: Stage 1 chronic kidney disease (CKD), estimated glomerular filtration rate (eGFR) ≥90 ml/min/...
<p>Abbreviations. BP, blood pressure; eGFR, estimated glomerular filtration rate; ACEI, angiotensin ...
<p>Data are expressed as number (percentage) for categorical variables and mean±SD or median (25<sup...
<p>Data are presented as mean ± SEM or median (inter-quartile range [IQR]) for continuous variables ...
<p>*p-interaction (Wald test) between eGFR category and inpatient revascularisation and mortality: 0...
<p>Groups 1, 2, 3 and 4 were made up of patients with eGFR ≥45 ml/min/1.73 m<sup>2</sup> without PAD...
<p>Patients have been assigned to two groups by the median of eGFR at baseline (99.19 ml/min/1.73 m<...
<p>P-value < 0.05 = *, p value < 0.01 = **, all values are compared with eGFR ≥90 ml/min/1.73 m² gro...
<p>*p-interaction (Wald test) between eGFR category and inpatient revascularisation and mortality: 0...
Objectives: To validate the performance of the most commonly used formulas for estimation of glomeru...